Sebaaly Camille 4
4 · Sunshine Biopharma, Inc · Filed Sep 23, 2019
Insider Transaction Report
Form 4
Sebaaly Camille
DirectorCFO and Secretary
Transactions
- Award
Common Stock
2019-09-02$0.00/sh+13,000,000$13,000→ 18,861,719 total - Award
Common Stock
2019-09-11$0.00/sh+11,000,000$11,000→ 29,861,719 total
Footnotes (1)
- [F1]Effective February 1, 2019, Issuer effectuated a reverse stock split wherein 1 share of Common Stock was issued for each 20 shares of the issued and outstanding Common Stock of the Issuer resulting in Reporting Person owning 5,861,719 shares of Common Stock of the Issuer as of that date.